Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference

Targeting metabolic reprogramming is an emerging strategy in cancer therapy. However, clinical attempts to target metabolic reprogramming have been proved to be challenging, with metabolic heterogeneity of cancer being one of many reasons that causes treatment failure. Here, we stratified non-small...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Ting-Chun, Huang, Kuo-Yen, Yang, Shuenn-Chen, Wu, Sean, Chung, Wei-Chia, Chang, Yih-Leong, Hong, Tse-Ming, Wang, Shu-Ping, Chen, Hsuan-Yu, Hsiao, Tzu-Hung, Yang, Pan-Chyr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364124/
https://www.ncbi.nlm.nih.gov/pubmed/32695876
http://dx.doi.org/10.1016/j.omto.2020.06.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364124/
https://www.ncbi.nlm.nih.gov/pubmed/32695876
http://dx.doi.org/10.1016/j.omto.2020.06.012

Ejemplares similares